The Enigmatic Nature of OpenAI’s Converge 2 Program Revealed

In December, OpenAI revealed it had begun accepting applications for its second iteration of a six-week accelerator program, initially launched in 2022, with little fanfare following the announcement. Despite the silence, sources confirm that Converge 2, the startup accelerator program by OpenAI, was successfully conducted. OpenAI’s Startup Fund invested in several startups from this cohort, as verified by TechCrunch.

The second iteration, named Converge 2, stood out from the typical cycle of accelerator programs which usually announce the startups that have joined or completed their programs. Given that such announcements can significantly contribute to the startups’ success, the silence around Converge 2 was unusual.

For a long period, speculation flourished on a tech forum, with participants questioning the actual occurrence of Converge 2. Applicants and curious onlookers alike were left in the dark, with no updates on selection or rejection, a scenario that seemed to puzzle many in Silicon Valley given OpenAI’s prominent position, based on TechCrunch’s reports.

This absence of communication was peculiar, especially considering the transparency with which OpenAI conducted Converge I earlier in 2023. OpenAI openly solicited applications and proudly announced its first set of investments from the OpenAI Startup Fund during this phase. In anticipation of the second cohort, slated to start in March 2024 and conclude by April, applications were welcomed from December 2023. Yet, the fallout was a profound silence—no announcements regarding the selected companies were made.

Despite repeated inquiries, OpenAI did not acknowledge whether the program was conducted. Founders and industry watchers shared their perplexities online and with us, reflecting widespread curiosity.

The rationale behind OpenAI’s reluctance to disclose the graduates of the cohort remains undisclosed, raising questions about potentially strict NDAs or an intrinsic culture of discretion. Converge 1, for instance, maintained a low-profile communication strategy, with participant companies like Cursor.AI being disclosed incrementally.

Since early 2023, the spotlight on OpenAI has intensified markedly, especially amid reports of the company aspiring for another funding round that would elevate its valuation to $100 billion. Following Converge 1 and 2, Sam Altman was replaced by Ian Hathaway as the fund owner, a transition that hasn’t slowed the fund’s investments. Recent beneficiaries include AI innovations like Heeyo, Thrive AI Health, New Computer, and Ambience Healthcare, a few of which are rumored to have participated in a Converge program, although specific details remain confidential.

Concerning the program’s inner workings, information is sparing. An insider highlighted the primary advantage as being access to OpenAI’s experts and pre-release technologies, suggesting stringent NDAs might be in place, reflecting OpenAI’s preference for confidentiality, as noted in a recent Vox report.